(Q36904871)

17 August 2017

1 reference

title

Novel therapeutic usage of low-dose doxepin hydrochloride (English)

1 reference

17 August 2017

Haramandeep Singh

1

1 reference

17 August 2017

Philip M Becker

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Expert Opinion on Investigational Drugs

17 August 2017

published in

1 reference

17 August 2017

volume

16

1 reference

17 August 2017

issue

8

1 reference

17 August 2017

page(s)

1295-1305

1 reference

National Patterns of Medication Treatment for Depression, 1987 to 2001

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Pharmacokinetics of doxepin and desmethyldoxepin: an evaluation with the population approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Trimipramine, anxiety, depression and sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Doxepin in the Treatment of Primary Insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Protriptyline in obstructive sleep apnea: a double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Treatment options for sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Preliminary clinical experience with imipramine HCl in the treatment of sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Tricyclic antidepressants as long-acting local anesthetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: a survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

The addition of topical doxepin to corticosteroid therapy: an improved treatment regimen for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Demographics, assessment and management of pain in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Topical application of doxepin hydrochloride can reduce the symptoms of complex regional pain syndrome: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Antidepressants in the treatment of migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Efficacy of oral doxepin and piroxicam treatment for interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Doxepin toxicity in a child following topical administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Tricyclic antidepressants for functional nausea and vomiting: clinical outcome in 37 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Sleep disturbances in the elderly residing in assisted living: findings from the Maryland Assisted Living Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Diagnosis and treatment of sleep disorders in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Consequences of comorbid insomnia symptoms and sleep-related breathing disorder in elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

Nocturnal Melatonin Secretion and Sleep after Doxepin Administration in Chronic Primary Insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.8.1295

10.1517/13543784.16.8.1295

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference